Iradimed Corp (IRMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 83,814 | 73,242 | 65,562 | 53,303 | 41,815 |
| Cost of Goods | 19,490 | 16,892 | 15,404 | 12,021 | 9,765 |
| Gross Profit | 64,324 | 56,350 | 50,158 | 41,282 | 32,050 |
| Operating Expenses | 38,667 | 35,277 | 30,527 | 25,676 | 22,997 |
| Operating Income | 26,147 | 21,965 | 20,036 | 15,628 | 9,818 |
| Other Income | 2,214 | 2,310 | 1,703 | 553 | 19 |
| Pre-tax Income | 28,361 | 24,275 | 21,738 | 16,181 | 9,836 |
| Income Tax | 5,881 | 5,041 | 4,546 | 3,352 | 511 |
| Net Income Continuous | 22,480 | 19,234 | 17,193 | 12,829 | 9,326 |
| Net Income | $22,480 | $19,234 | $17,193 | $12,829 | $9,326 |
| EPS Basic Total Ops | 1.77 | 1.52 | 1.36 | 1.02 | 0.76 |
| EPS Basic Continuous Ops | 1.77 | 1.52 | 1.36 | 1.02 | 0.76 |
| EPS Diluted Total Ops | 1.75 | 1.50 | 1.35 | 1.02 | 0.74 |
| EPS Diluted Continuous Ops | 1.75 | 1.50 | 1.35 | 1.02 | 0.74 |
| EPS Diluted Before Non-Recurring Items | 1.75 | 1.50 | 1.35 | 1.02 | 0.74 |
| EBITDA(a) | $27,313 | $22,783 | $20,801 | $16,298 | $11,225 |